Director, Oncology Field Medical Excellence, Strategy and Operations

Role Description

The Field Medical Excellence, Strategy, and Operations Director will drive strategic and operational excellence to ensure that the Medical Science Liaison (MSL) team is optimally equipped to deliver high-impact scientific exchanges with healthcare professionals (HCPs) effectively and efficiently. This role involves supporting the Oncology Field Medical (OFM) team through the implementation of field initiatives, capability builds, project planning, establishment of frameworks for internal processes and field systems/operations. The Director will collaborate with field medical leadership to develop strategies that drive organizational excellence within the field.

This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following:

• Ensure frameworks and operational elements are in place to support execution and monitoring of key initiatives (e.g., FMEP framework, medical unmet need, congress framework).
• Partner with field leaders to identify medical capability needs and deliver timely innovative solutions to enhance skills and competencies, supporting continuous improvement in MSL engagement strategies, ensuring best-in-class scientific impact, high-quality engagement, and insights generation.
• Provide training to bolster proficiency across field medical systems and foster digital fluency, enhancing productivity and effectiveness (GenAI tools, Veeva CRM, PowerBI etc.).
• Continually evaluate and refine best-in-class processes, implementing new innovations and technologies to simplify complex procedures and drive performance for field medical teams.
• Oversee the maintenance and creation of systems (dashboards, analytical tools, Veeva CRM, etc.) for evaluating customer interactions, tracking progress towards goals, and enabling leadership teams to assess and coach performance.
• Oversee the operational execution of Field Medical Plans to ensure alignment to scientific exchange policies and processes, including support of audit/monitoring activities.
• Serve as the first point of escalation for field leadership, ensuring policies/guidance are applied prior to escalation, communicate governance and compliance related issues to the leadership team, and support audit/monitoring activities for OFM.
• Collaborate effectively with medical matrix partners, including US Medical Affairs Leads (USMALs), Medical Directors, MSL Directors, and Medical Communication and Scientific Training Directors, to deliver on responsibilities within the role.
• Responsible for supporting budget process for key field activities.
• Ability to travel 15 to 20%.

Qualifications

• MS, RN, PharmD, PhD or equivalent post-graduate degree, MBA or equivalent experience.
• 4 + years of pharmaceutical industry experience, including field-based experience in Medical Affairs.
• Experience leading significant change initiatives leveraging advanced project management skills.
• Must be US-based for consideration.

Requirements

• Pharmaceutical industry field-based medical experience.
• Documented ability to prioritize business needs and flexibility to address them when business appropriate.
• Demonstrated ability to utilize appropriate approaches for effective communication, influence, and leadership.
• Demonstrated leadership ability to work in matrix environment with senior management.
• Strong organizational, planning, and business acumen skills, as well as advanced project management skills with the ability to manage large projects simultaneously and manage conflicting priorities.
• Detailed working knowledge of or ability to quickly assimilate GSK policies, as well as medical guidance and ways of working documents.
• Demonstrated consistent performance.
• Oncology experience.

Benefits

Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Company Description

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.